Darling Ingredients Inc (DAR) and its health brand Rousselot said Wednesday the U.S. Patent and Trademark Office has granted a patent for Nextida GC, a collagen peptide, a protein-derived compound broken down for easier absorption, designed to help manage after-meal blood sugar levels without pharmaceutical intervention.
The patent covers both the production process and the use of Nextida GC as a dietary supplement, the company said, positioning it as a natural option for metabolic support, the body's ability to regulate energy and blood glucose.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments